Genomic Sequencing Predicts Risk of Kidney Cancer Relapse Genomic Sequencing Predicts Risk of Kidney Cancer Relapse
Twelve genetic mutations in clear-cell renal cell carcinoma may predict which patients will experience recurrence; they could also help personalize adjuvant treatment, researchers say.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Hematology | Kidney Cancer | Renal Cell Carcinoma | Urology & Nephrology